Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.74 | N/A |
| PEG Ratio (TTM) | 2.11 | N/A |
| P/S Ratio (TTM) | 0.98 | N/A |
| P/B Ratio (TTM) | 3.65 | N/A |
| P/FCF Ratio (TTM) | 21.01 | N/A |
| Price to 5YR AVG Earnings Ratio | -16.16 | N/A |
| Price to 5YR AVG FCF Ratio | 31.06 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.77% | N/A |
| ROE (TTM) | 20.91% | N/A |
| Net Profit Margin (TTM) | 5.22% | N/A |
| ROIC 5YR AVG | -1.62% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 32.81% | -5.02% | 82.21% |
| Revenue | 1.97% | -0.41% | 5.33% |
| Net Income | 33.10% | -5.53% | 82.30% |
| Cash Flow | 47.98% | 127.51% | 81.97% |
Health (58%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.76 | N/A |
| Quick Ratio (TTM) | 1.46 | N/A |
| D/E Ratio (TTM) | 0.69 | N/A |
| Interest Coverage (TTM) | 5.98 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.58 | N/A |
| LTL to 5YR AVG FCF | 9.40 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.44% | N/A |